Table 2. Wald type II chi-square statistics of the linear mixed models for each HRQOL measure.
Variables | χ 2 | df | P value |
---|---|---|---|
Physical Health (PCS) | |||
Time | 95.024 | 1 | < .001* |
Gender | 15.049 | 1 | < .001* |
Time × gender | 4.843 | 1 | .028* |
Comorbidity burden: | |||
Total comorbidity conditions | 16.819 | 2 | < .001* |
Charlson comorbidity categories | 12.798 | 2 | .002* |
Comorbidity burden × gender: | |||
Total comorbidity conditions | 9.448 | 2 | .009* |
Charlson comorbidity categories | 3.715 | 2 | .156 |
Comorbidity burden × time: | |||
Total comorbidity conditions | 0.348 | 2 | .840 |
Charlson comorbidity categories | 0.990 | 2 | .610 |
Mental health (MCS) | |||
Time | 44.794 | 1 | < .001* |
Gender | 1.351 | 1 | .245 |
Time × gender | 0.206 | 1 | .650 |
Comorbidity burden: | |||
Total comorbidity conditions | 2.143 | 2 | .343 |
Charlson comorbidity categories | 4.787 | 2 | .091 |
Comorbidity burden × gender: | |||
Total comorbidity conditions | 2.775 | 2 | .250 |
Charlson comorbidity categories | 5.135 | 2 | .077 |
Comorbidity burden × time: | |||
Total comorbidity conditions | 4.823 | 2 | .090 |
Charlson comorbidity categories | 2.344 | 2 | .310 |
Disease-specific HRQoL (SAQ) | |||
Time | 248.309 | 1 | < .001* |
Gender | 15.787 | 1 | < .001* |
Time × gender | 1.564 | 1 | .211 |
Comorbidity burden: | |||
Total comorbidity conditions | 2.035 | 2 | .362 |
Charlson comorbidity categories | 7.115 | 2 | .029* |
Comorbidity burden × gender: | |||
Total comorbidity conditions | 13.761 | 2 | .001* |
Charlson comorbidity categories | 3.132 | 2 | .209 |
Comorbidity burden × time | |||
Total comorbidity conditions | 6.877 | 2 | .032* |
Charlson comorbidity categories | 0.906 | 2 | .636 |
*P values < 0.05 were considered significant.